Ankit Shah
Center for Drug Evaluation and Research
ORCID: 0000-0002-9771-8777Immunology and MicrobiologyMedicineNeuroscience
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 4 papers. Top paper: “FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer”.
108 citations
Mirat Shah, Gwynn Ison, Haley Gittleman, Mallorie H. Fiero, Ankit Shah +20 more
N/A
5 citations
Curtis Tilves, Hua Ding, Shaoguang Wu, Jada C. Domingue, Camilo A. Ruiz-Bedoya +12 more
N/A
30 citations
Ankit Shah, Hyowon Lee, Chi Hwan Lee, Ziheng Wang
4 citations
Kamar Godder, Jingyan Wang, Justin S. Collazo, Robyn Konicki, Moran Choe +15 more